Moneeb Ehtesham

A herpes simplex virus type 1 mutant with gamma 34.5 and LAT deletions effectively oncolyses human U87 glioblastomas in nude mice.

In situ adenoviral interleukin 12 gene transfer confers potent and long-lasting cytotoxic immunity in glioma.

The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma.

Treatment of intracranial glioma with in situ interferon-gamma and tumor necrosis factor-alpha gene transfer.

Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand.

Generation of neural progenitor cells from whole adult bone marrow.

Intratumoral dendritic cell vaccination elicits potent tumoricidal immunity against malignant glioma in rats.

Development of an intracranial ependymoma at the site of a pre-existing cavernous malformation.

Neural stem cells as delivery vehicles.

Intratumoral T cell subset ratios and Fas ligand expression on brain tumor endothelium.

Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4.

Recent progress in immunotherapy for malignant glioma: treatment strategies and results from clinical trials.

Small interference RNA modulation of IL-10 in human monocyte-derived dendritic cells enhances the Th1 response.

Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma.

Stem cell therapies for malignant glioma.

Stem cells as vehicles for the treatment of brain cancer.

Integrating spatially resolved three-dimensional MALDI IMS with in vivo magnetic resonance imaging.

CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal abnormalities.

Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.

CXCR4 mediates the proliferation of glioblastoma progenitor cells.

T2 detection of tumor invasion within segmented components of glioblastoma multiforme.

Use of neural stem cells as therapeutic vehicles for the treatment of malignant glioma.

Preclinical molecular imaging of the translocator protein (TSPO) in a metastases model based on breast cancer xenografts propagated in the murine brain.